Skip to main navigation
Skip to search
Skip to main content
Scholars @ UT Health San Antonio Home
Help & FAQ
English
Español
Home
Profiles
Research units
Publications
Datasets
Search by expertise, name or affiliation
The CoVID-TE risk assessment model for venous thromboembolism in hospitalized patients with cancer and COVID-19
the CCC19 consortium
Research output
:
Contribution to journal
›
Article
›
peer-review
25
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'The CoVID-TE risk assessment model for venous thromboembolism in hospitalized patients with cancer and COVID-19'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Risk Assessment
100%
Patient
42%
Incidence
28%
Patient with Cancer
28%
Malignant Neoplasm
21%
Inpatient
14%
Cancer Treatment
14%
Logistic Regression Analysis
7%
Thrombosis
7%
Cohort Analysis
7%
Venous Thromboembolism
7%
Antithrombotic
7%
D-Dimer
7%
Cancer Diagnosis
7%
Vulnerable Population
7%
Cancer Therapy
7%
Bootstrapping
7%
Hispanic
7%
Pharmacology, Toxicology and Pharmaceutical Science
Incidence
28%
Arterial Thromboembolism
28%
Malignant Neoplasm
21%
Anticoagulant Agent
7%
D Dimer
7%
Venous Thromboembolism
7%
Thrombosis
7%
Immunology and Microbiology
COVID-19
57%
Incidence
28%
Vulnerable Population
7%
Time
7%